Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Dapeng Li, David R. Martinez, Alexandra Schäfer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Tyler D. Gavitt, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113248-113248
Open Access | Times Cited: 11
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
A. Brenda Kapingidza, Daniel J. Marston, Caitlin Harris, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Protein-based Nanoparticle Vaccine Approaches Against Infectious Diseases
Daniel Tapia, Arturo Reyes‐Sandoval, Javier I. Sanchez-Villamil
Archives of Medical Research (2023) Vol. 54, Iss. 3, pp. 168-175
Closed Access | Times Cited: 10
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
Ivy Phung, Kristen A. Rodrigues, Ester Marina-Zárate, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S. Arunachalam, Na‐Young Ha, S. Moses Dennison, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 758
Closed Access | Times Cited: 3
Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2
Molly R. Braun, C Martínez, Emery G. Dora, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
C. Pierre, Lily E. Adams, Kara Anasti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines
Emily L. Meany, John H. Klich, Carolyn K. Jons, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Baculovirus-expressed self-assembling SARS-CoV-2 nanoparticle vaccines targeting the S protein induce protective immunity in mice
Xingjian Liu, Haozhi Song, Jianmin Jiang, et al.
Process Biochemistry (2023) Vol. 129, pp. 200-208
Open Access | Times Cited: 6
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Design of a pan-betacoronavirus vaccine candidate through a phylogenetically informed approach
Éric Lewitus, Hongjun Bai, Morgane Rolland
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 5
A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage
Harikrishnan Balachandran, Kyle Kroll, Karen Terry, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012439-e1012439
Open Access | Times Cited: 1
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 37-37
Open Access | Times Cited: 4
SARS-CoV-2 S Glycoprotein Stabilization Strategies
Borys Pedenko, Guidenn Sulbarán, Delphine Guilligay, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 558-558
Open Access | Times Cited: 3
Deep generative models predict SARS-CoV-2 Spike infectivity and foreshadow neutralizing antibody escape
Noor Youssef, Sarah F. Gurev, Fadi Ghantous, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
Catherine Berry, Vincent Pavot, Natalie G. Anosova, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
Goda Baddage Rakitha Malewana, Victoria Stalls, Aaron J. May, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Computationally designed mRNA-launched protein nanoparticle vaccines
G. Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
Marco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Scroll to top